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T he prevalence of heart failure (HF) is more than 23 million worldwide, 1 and despite an improvement in survival rate, the mortality among men and women is still approximately 50% within 5 y.
2 Cardiorespiratory fitness, expressed as peak oxygen uptake (V o 2peak ), is positively related to mortality and hospitalization in HF patients. 3 Aerobic exercise training improves V o 2peak , 6-min walk distance (6MWD), health-related quality of life (HRQoL), and vascular function in HF patients. [4] [5] [6] [7] [8] Aerobic exercise training is the most documented and established training modality for HF patients, 9 and current guidelines recommend aerobic exercise training at moderate to high intensity (70%-80% of V o 2peak ) for approximately 30 min, 2 to 3 times per week. 8, 10 However, long-term adherence to exercise training in this patient group is low. 11 Common barriers for exercise training are lack of time and energy, 11 and, therefore, exercise modalities optimized in regard to training intensity, time efficiency, energy expenditure, and frequency are needed to increase adherence. 12 Because of the increased risk associated with an increased load on the heart during resistance training, resistance training has generally not been recommended for HF patients. 13 However, resistance training at intensities ≤60% of 1 repetition maximum (1-RM) is clinically accepted. 14, 15 There is robust evidence that HF patients who engage in exercise training increase their aerobic power and submaximal exercise capacity, mainly by reversing peripheral abnormalities, such as endothelial dysfunction, skeletal muscle wasting, and ventilatory inefficiency. 11 Theoretically, HF patients might benefit from strength training that aims at improving peripheral adaptations. Accordingly, resistance training has been shown to be beneficial with regard to V o 2peak , 6MWD, HRQoL, and vascular function, as well as to have a positive effect on recreational and activities of daily living in HF patients. 4, [16] [17] [18] It is unclear whether a resistance training program, with low resistance (≤40% of 1-RM) for a short duration (∼15 min), can be as effective as aerobic moderateintensity training in HF patients.
Therefore, the aim of present study was to evaluate the effect of low-volume time-based resistance exercise training (TRE) using ≤40% of 1-RM, a dynamic resistance exercise modality with less time required compared with the traditional moderate-intensity endurance training. The primary outcome was the effect of training on 6MWD. Whereas, secondary outcomes included the effect of training on cardiorespiratory fitness, HRQoL, and vascular function in patients with mild to moderate (New York Heart Association [NYHA] class I-II) HF. We hypothesized that TRE, despite less time required and lower energy expenditure, would be as effective as moderate-intensity cycling. 
METHODS

PATIENTS
Twenty-eight HF patients NYHA class I-II with different etiologies, a history of reduced ejection fraction ≤40%, clinically stable, and receiving optimal pharmacological treatment (angiotensin-converting enzyme inhibitors and β-blockers) were included in the study. Patients diagnosed with HF within 12 mo were recruited from the hospital patient registers in the Region of Copenhagen (Figure 1 ). Patients were screened with a medical history interview, physical examination, blood chemistry analysis, and a resting 12-lead electrocardiogram. Those patients with myocardial infarction within 2 mo, intermittent claudication, aneurysm in a femoral artery, moderate to severe cardiac valve disease, and arrhythmias (eg, atrial fibrillation and frequent premature ventricular contractions) were excluded. Other exclusion criteria were moderate to severe chronic obstructive pulmonary disease with forced expiratory volume <60% and renal failure (creatinine >2.5 mg/dL). Patients were instructed to continue their medication during the study. The study was approved by the Ethic Committee of the Capital Region of Denmark (H-3-2013-048), registered on ClinicalTrials.org (NCT02732990) and conducted in accordance with guideline of the Declaration of Helsinki. Written informed consent was obtained from all patients before enrollment in the study.
EXPERIMENTAL DESIGN
This study was an open-label randomized controlled trial. After the first experimental day, patients were assigned (1:1 allocation ratio by sealed envelope lottery) to either (1) aerobic moderate-intensity cycling (AMC; n = 14) or (2) low-volume time-based resistance training (TRE; n = 14). Both groups performed 3 exercise sessions per week for 6 wk.
MEASUREMENTS Assessments
Assessments were performed on 2 separate days and in the same order before and after the intervention. On day 1, patients refrained from alcohol, caffeine, and exercise 24 hr prior to the visit. On day 2, standard echocardiography was performed (Vivid 9, GE Healthcare) ( Figure 1 ).
Day 1
Body composition
Body weight was measured on a digital scale (MT32, M5, Bisco) and body composition was assessed by dual-energy x-ray absorptiometry (Lunar Prodigy Advance, GE Healthcare).
Health-related quality of life
The Minnesota Living With Heart Failure Questionnaire 19 was used to measure the perception of the impact of living with HF in regard to daily living and physical activity.
Vascular function
Endothelial function was evaluated by flow-mediated dilation (FMD). 20 Patients were prepared in accordance with published guidelines. 21 Flow-mediated dilation was assessed in the superficial femoral artery and in accordance with published guidelines. 21 Endothelium-dependent vasodilation was calculated as the percentage increase in arterial diameter, intima to intima 22 (Brachial Analyzer Research, version 6). Following 15 min of rest, patients completed 2-min passive leg movement using a 1-legged knee extensor ergometer (60 rpm) for evaluation of endothelial nitric oxide function, 23 followed by 3 min of active 1-legged knee extensor exercise (12 W). Femoral arterial blood flow during passive and active leg movement and FMD was measured by ultrasonography (LOGIQ E9, GE Healthcare) with a linear probe operating at a B-mode frequency of 9 MHz and Doppler frequency of 4.1 to 5.0 MHz. Leg blood flow during passive and active leg movement was expressed as area under the curve.
Exercise test
To determine V o 2peak and exercise capacity reported as peak watts (W peak ), patients completed an incremental cycling test on a cycle ergometer (Monark 839E; Monark) with continuous measurement of oxygen uptake (Cosmed CPET). The test consisted of a 5-min warm-up at 50 W, then the workload was increased by 10 W every minute until volitional exhaustion or 2 of the following criteria were met: plateau of oxygen uptake with increasing workloads (indicative of V o 2peak ); respiratory exchange ratio >1.1; cycling cadence <60 rpm for more than 10 sec. V o 2peak is reported as the highest value averaged more than 30 sec during the incremental test.
Following 30 min of rest, 6MWD 24 was measured. The patients were instructed to walk the greatest distance possible in 6 min, at a self-determined walking speed, pausing to rest if needed. The patients walked between 2 cones that were 30 m apart.
Exercise intervention Aerobic moderate-intensity cycling (AMC):
The AMC consisted of a 10-min standardized warm-up at 50% of W peak attained during the incremental cycling test and 35 min of continuous cycling at 75% of W peak .
Time-based resistance exercise training (TRE):
The TRE was performed on machines (Technogym) and consisted of 4 sets of isotonic resistance exercises involving major upper and lower body muscle groups (chest press, rowing, leg press, and leg extension). At the first training session, the patients were familiarized to the machines and completed a test to determine 1 RM. 25 During the training intervention, the workload was initially set at 25% of 1RM and then increased to 40% of 1RM. Each exercise consisted of four 30-sec sets that allowed for 15 to 20 repetitions to be completed. There was a 20-sec break between sets and a 60-sec break between the 4 resistance exercises. Patients were instructed to maintain muscle tension at all times during the exercises. A 10-min standardized warm-up on a cycle ergometer (50% W peak ) was performed prior to TRE.
Energy expenditure TRE:
During 2 training sessions (midway through and at the end of the training intervention), V o 2peak was measured (Cosmed CPET) for calculation of mean energy expenditure during a training session (warm-up included). Energy expenditure during warm-up was based on calculation from the mean watts during the warm-up. 26 
AMC:
The energy expenditure during AMC was based on calculation from mean watts during a training session and warm-up. 26 Laboratory analysis Blood samples were obtained from an antecubital vein on the experimental day, and venous plasma analysis of resting interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor α (TNF-α) were measured by enzyme-linked immunosorbent assay (Meso Scale Discovery). Venous plasma resting catecholamines were determined with a radioimmunoassay (LDN).
STATISTICAL ANALYSIS
One-way analysis of variance was used to compare between-group baseline characteristics. A 2-way (group × time) repeated measures analysis of variance was used to compare pre-and post-intervention changes within and between groups. For all analysis of variance testing, the Tukey post hoc test was used to examine the difference between means in the event of a significant finding. A significant interaction indicated that the outcome variable was influenced differently by the training regimen in the groups. All data are presented as mean ± standard error of the mean. All analyses were conducted using SigmaPlot, version 13 (Systat Software), and statistical significance was accepted with P < .05. Sample size was based on a similar study from our research group with patients with chronic obstructive pulmonary disease using 6MWD of 54 m ± standard deviation of 50 m as the true difference between groups, power 80%, and α level of 5%. 27 
RESULTS
PATIENT CHARACTERISTICS
Patient characteristics and intervention-induced changes are listed in Table 1 . At baseline, there were no differences between groups in any of the parameters listed in Table 1 . Two patients were excluded from the TRE group during the intervention period (1 patient due to 2 incidents of dizziness and headache during training sessions and another patient due to unrelated disease) so that a total of 26 HF patients completed the study (Figure 2) .
EXERCISE TRAINING
All patients in the AMC group and the TRE group completed all training sessions. During the 15 min of effective training (25 min minus 10 min of warm-up), the TRE group trained at a mean of 60 ± 4% of V o 2peak . The AMC group trained at an estimated 59 ± 2% of V o 2peak . The patients in both groups showed similar training compliance (AMC: 18 ± 0; TRE: 18 ± 0 training sessions, respectively). The calculated energy expenditure during individual training sessions was higher in the AMC group than in the TRE group (P < .05; Table 2 ).
CARDIORESPIRATORY FITNESS
The 6MWD increased in both groups (AMC: P = .006 and TRE: P = .036) and there was no difference between groups ( Table 2 ). The V o 2peak and W peak increased in both AMC group (P < .001) and TRE group (P = .001) after training with no difference between groups (Table 2) .
HEALTH-RELATED QUALITY OF LIFE
Both AMC and TRE groups improved their Minnesota Living With Heart Failure Questionnaire scores after the training intervention (P < .05), and there was no difference between groups.
BODY COMPOSITION
Whole body mass, whole lean body mass, and whole body fat mass were not different within or between groups before and after the training intervention (Table 1) .
CARDIOVASCULAR FUNCTION AND STRUCTURE
Ejection Fraction
Ejection fraction remained unchanged with training (mean change from baseline: AMC: 0.4 ± 2.5% vs TRE: −1.0 ± 3.0%), with no significant difference between groups.
Leg Blood Flow During Passive and Active Leg Movement
Before and after the training, leg blood flow increased similarly in both groups during passive leg movement (P < .05; Table 2 ). There was no difference in leg blood flow during active leg movement within or between groups before and after the training intervention (Table 2) .
Endothelial Function
The peak diameter of the femoral artery increased (P < .001) after occlusion in both groups (Table 3) . No difference in the FMD was observed within or between groups before and after the training intervention. Data were available for n = 13 in the AMC group and n = 11 in the TRE group. 
Inflammatory Markers and Catecholamines
Baseline resting cytokines IL-6, IL-10, and TNF-α were not different within or between AMC and TRE groups before and after the training intervention (Table 1) . Similarly, resting epinephrine and norepinephrine were not different within or between groups before and after training intervention (Table 1) .
DISCUSSION
In this randomized controlled study, we found that 6 wk of TRE is as effective as AMC in regard to improving 6MWD, cardiorespiratory fitness, and HRQoL in NYHA-class I-II HF patients.
CARDIORESPIRATORY FITNESS
Previous evidence suggests that dynamic strength training is beneficial with regard to increases in aerobic capacity, 6MWD, HRQoL, endothelial function, and inflammatory markers in HF patients. [16] [17] [18] [28] [29] [30] The present data extend these observations by demonstrating that time-efficient resistance training at a low intensity can also improve submaximal exercise (6MWD by 4%), V o 2peak by 7%, and W peak by 8% in patients with mild HF.
Both TRE and AMC improved 6MWD after 6 wk of training with no difference between the groups. That TRE-improved 6MWD is consistent with previous observations showing that resistance training has the ability to improve 6MWD when compared with no training. 31 Six-minute walk distance has been observed to be an important measure of functionality and a reliable outcome for clinical trials. 32 The fact that TRE improved 6MWD, despite less time spent exercising, suggests that this exercise modality might be beneficial and relevant for improving functionality in HF patients.
Time-based resistance exercise training also improved V o 2peak , which is in contrast with previous observations showing no improvement in V o 2peak despite improved functionality. 30 The improved V o 2peak in this study may be explained by the dynamic interval nature of the TRE modality used. The mean training intensity was ∼60% of V o 2peak during a session (exercise and recovery), reaching even higher peaks in V o 2peak during the exercise period.
The effect of moderate-intensity aerobic training on V o 2peak in HF patients is well established, 4, 8 and aerobic training remains the basis in the general recommendation for stable HF patients. 9 In a large systematic review, it was observed that aerobic training alone was most efficient in regard to relative improvement in V o 2peak , when compared with (1) strength training; (2) combined strength and aerobic training; and (3) inspiratory muscle training. 4 With a 13% increase in V o 2peak , our data support that aerobic training is an effective exercise modality for HF patients. In addition, resistance training that also stresses the aerobic system might also be a beneficial exercise modality for HF patients in regard to improving V o 2peak . 4, 33, 34 
HEALTH-RELATED QUALITY OF LIFE
We found that both AMC and TRE improved HRQoL by 7 and 6 points, respectively, on the Minnesota Living With Heart Failure Questionnaire scale, which is greater than the 4 points recognized as a clinically important difference. 35 The magnitude of improvement in HRQoL after our training intervention is comparable with most recent Cochrane review on exercise training in HF patients across 13 trials. 6 It has previously been proposed that the type of training, frequency, duration, and intensity may influence the HRQoL score. 36 However, in the present study, we evaluated 2 different training modalities, with different intensities and different time requirements, but with similar improvements in HRQoL. This indicates that TRE, despite significantly lower-energy expenditure and time spent, is sufficient to improve HRQoL.
VASCULAR FUNCTION, INFLAMMATORY MARKERS, AND CATECHOLAMINES
Regular exercise training has been shown to improve endothelial function in HF patients. 37 In the present study, we did not observe any difference in FMD or in the hyperemic response to passive leg movement after the training intervention in either of the groups. It has previously been observed that 8 wk of daily handgrip exercise improves endothelial-dependent Data are presented as mean ± SEM. P values refer to 2-way repeated measures ANOVA between the 2 training groups (n = 13 in aerobic moderate-intensity cycling; n = 12 in lowvolume time-based resistance training).
vasodilation in the arm, 38 and 4 wk of endurance training 6 times per wk improves endothelial function, 5 suggesting that the lack of response in the present study may be related to the lower training frequency. The short intervention period in our study could also explain the unaltered vascular function. Maiorana et al 39 showed improved endothelium-dependent vascular function after 8 wk of combined resistance and aerobic exercise training with 3 weekly training sessions. In contrast, 16 wk of aerobic moderate endurance training with 3 training sessions per wk showed no improvement in endothelial function. 40 A likely explanation for the unaltered vascular function could also be related to an efficient vascular function in the patients in present study 41 and/or that patients in our study were optimally treated pharmacologically. 42 However, when compared with healthy individuals, the FMD response was lower in both AMC and TRE. 43 No changes in inflammatory makers (IL-6, IL-10, or TNF-α) were observed in any of the groups after the training intervention. Inflammatory markers are well known to be elevated in HF patients, and it is suggested that the extent of cytokine production directly correlates with the severity of the disease process. 44 The patients in our study were HF patients with mild symptoms of HF, and this may explain that cytokine levels did not respond to the training. 45 However, it has also been shown that regular training does not alter systemic serum TNF-α and IL-6 but reduces the local expression of TNF-α and IL-6 in skeletal muscle of HF patients. 46 CLINICAL RELEVANCE Cardiac rehabilitation is an important part of the nonpharmacological management of HF patients, and because of the well-documented beneficial effects, exercise training is a central component. 47 Adherence to exercise is generally poor in HF patients, due both to lack of time and lack of energy.
11
Because of limited health care resources, time is an important factor when designing rehabilitation programs that also include education, social support, and nutritional advice. 47 Thus, introducing a time-effective exercise modality, such as TRE, could, therefore, be of great clinically interest, both from a patient perspective and for health care providers.
LIMITATIONS
The patients in the present study were HF patients (NYHA-class I-II) who demonstrated a good baseline exercise capacity, which may suggest that these patients had a lower disease severity. Therefore, this training program needs to be evaluated in patients with more severe HF before being recommended for use with these patients.
In the present study, the intervention period was relative short, there was no progression in exercise intensity throughout the intervention period, and the AMC group performed only moderate-intensity training. It is plausible that a longer intervention period, a progression of exercise intensity, and a higher intensity for the AMC would have led to greater improvement in cardiorespiratory fitness both within and between groups.
Although the number of patients included in the present study was relatively low, previous studies have observed similar observations with similar sample sizes in regard to cardiorespiratory fitness. 4 However, the inability to detect any difference between groups may be a result of this relative small sample size.
CONCLUSION
In summary, we demonstrate that TRE is tolerated and a beneficial exercise modality for patients with mild to moderate HF (NYHA class I-II). Despite the 44% less time required and 35% lower-energy expenditure, TRE was equally effective compared with AMC for improvements in 6MWD, cardiorespiratory fitness, and HRQoL. Therefore, TRE appears to be a time-efficient exercise modality for improving cardiorespiratory fitness in HF patients.
